These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Oral dosage schedules for mexiletine. Pottage A Postgrad Med J; 1977; 53 Suppl 1():155-7. PubMed ID: 876949 [No Abstract] [Full Text] [Related]
43. A multiple-dose study of mexiletine (Kö 1173). Cereghino JJ; Brock JT; Van Meter JC; Penry JK; Kupferberg HJ; Smith LD; White BG Epilepsia; 1975 Dec; 16(5):673-7. PubMed ID: 1222743 [TBL] [Abstract][Full Text] [Related]
44. [Pharmacokinetics and relative bioavailability of a new oral sustained-release form of mexiletine in healthy subjects]. Santoni Y; Bruno R; Fornaris M; Egre A; Danays T; Cano JP Therapie; 1983; 38(4):341-4. PubMed ID: 6648880 [No Abstract] [Full Text] [Related]
45. A single-dose study of mexiletine (Kö 1173). Cereghino JJ; Wilder BJ; Kupferberg HJ; Yonekawa WD; Perchalski RJ; Ramsey RE; White BG; Penry JK; Smith LD Epilepsia; 1975 Dec; 16(5):665-72. PubMed ID: 1222742 [TBL] [Abstract][Full Text] [Related]
46. Long-term treatment of ventricular arrhythmias with oral mexiletine. Talbot RG; Julian DG; Prescott LF Am Heart J; 1976 Jan; 91(1):58-65. PubMed ID: 53994 [TBL] [Abstract][Full Text] [Related]
47. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias. Hashimoto K; Ishii M; Komori S J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706 [TBL] [Abstract][Full Text] [Related]
48. Kinetics of oral and intravenous mexiletine: lack of effect of cimetidine and ranitidine. Brockmeyer NH; Breithaupt H; Ferdinand W; von Hattingberg M; Ohnhaus EE Eur J Clin Pharmacol; 1989; 36(4):375-8. PubMed ID: 2737230 [TBL] [Abstract][Full Text] [Related]
49. [Mexiletine, an anti-arrhythmia agent for acute stage of myocardial infarction]. Hayakawa H; Ino T Nihon Rinsho; 1983 Dec; 41(12):2748-55. PubMed ID: 6674559 [No Abstract] [Full Text] [Related]
50. A rapid method for the determination of plasma mexiletine levels by gas chromatography. Bradbrook ID; James C; Rogers HJ Br J Clin Pharmacol; 1977 Jun; 4(3):380-2. PubMed ID: 901709 [No Abstract] [Full Text] [Related]
51. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia. Horowitz LN; Greenspan AM; Spielman SR; Frye SJ; Yacone LA; Lowenthal DT Clin Pharmacol Ther; 1985 Jun; 37(6):644-8. PubMed ID: 2408808 [TBL] [Abstract][Full Text] [Related]
52. A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine. Upward JW; Holt DW; Jackson G Eur Heart J; 1984 Mar; 5(3):247-52. PubMed ID: 6723694 [TBL] [Abstract][Full Text] [Related]
53. Mexiletine analysis in blood and plasma using gas chromatography and nitrogen-selective detection. Smith KJ; Meffin PJ J Chromatogr; 1980 Mar; 181(3-4):469-72. PubMed ID: 7391161 [No Abstract] [Full Text] [Related]
54. Improved gas-liquid chromatographic method for measurement of mexiletine in plasma. Kacprowicz AT Clin Chem; 1982 Jan; 28(1):245-6. PubMed ID: 7055924 [No Abstract] [Full Text] [Related]
55. Improved high-performance liquid chromatographic assay for the stereoselective determination of mexiletine in plasma. Abolfathi Z; Bélanger PM; Gilbert M; Rouleau JR; Turgeon J J Chromatogr; 1992 Sep; 579(2):366-70. PubMed ID: 1429987 [TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics and nondialyzability of mexiletine in renal failure. Wang T; Wuellner D; Woosley RL; Stone WJ Clin Pharmacol Ther; 1985 Jun; 37(6):649-53. PubMed ID: 4006364 [TBL] [Abstract][Full Text] [Related]
57. A modified gas-liquid chromatographic assay to monitor plasma mexiletine in a tinnitus study. Pilling M; Tse J; Chan K Methods Find Exp Clin Pharmacol; 1982; 4(4):243-7. PubMed ID: 7121133 [TBL] [Abstract][Full Text] [Related]
58. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias. Rutledge JC; Harris F; Amsterdam EA J Am Coll Cardiol; 1985 Oct; 6(4):780-4. PubMed ID: 4031292 [TBL] [Abstract][Full Text] [Related]
59. The effect of spontaneous changes in urinary pH on mexiletine plasma concentrations and excretion during chronic administration to healthy volunteers. Johnston A; Burgess CD; Warrington SJ; Wadsworth J; Hamer NA Br J Clin Pharmacol; 1979 Oct; 8(4):349-52. PubMed ID: 41549 [TBL] [Abstract][Full Text] [Related]
60. [Experimental study of an ampicillin suppository (KS-R1) in adults and children]. Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]